 |
PDBsum entry 1fv3
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Toxin
|
 |
|
Title:
|
 |
The hc fragment of tetanus toxin complexed with an analogue of its ganglioside receptor gt1b
|
|
Structure:
|
 |
Tetanus toxin heavy chain. Chain: a, b. Fragment: c-terminal domain of heavy chain. Engineered: yes
|
|
Source:
|
 |
Clostridium tetani. Organism_taxid: 1513. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.239
|
R-free:
|
0.306
|
|
|
Authors:
|
 |
C.Fotinou,P.Emsley,I.Black,H.Ando,H.Ishida,M.Kiso,K.A.Sinha, N.F.Fairweather,N.W.Isaacs
|
Key ref:
|
 |
C.Fotinou
et al.
(2001).
The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.
J Biol Chem,
276,
32274-32281.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
18-Sep-00
|
Release date:
|
05-Sep-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P04958
(TETX_CLOTE) -
Tetanus toxin from Clostridium tetani (strain Massachusetts / E88)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1315 a.a.
451 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.68
- tentoxilysin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of 76-Gln-|-Phe-77 bond in synaptobrevin 2.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
276:32274-32281
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.
|
|
C.Fotinou,
P.Emsley,
I.Black,
H.Ando,
H.Ishida,
M.Kiso,
K.A.Sinha,
N.F.Fairweather,
N.W.Isaacs.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Tetanus toxin, a member of the family of Clostridial neurotoxins, is one of the
most potent toxins known. The crystal structure of the complex of the
COOH-terminal fragment of the heavy chain with an analogue of its ganglioside
receptor, GT1b, provides the first direct identification and characterization of
the ganglioside-binding sites. The ganglioside induces cross-linking by binding
to two distinct sites on the Hc molecule. The structure sheds new light on the
binding of Clostridial neurotoxins to receptors on neuronal cells and provides
important information relevant to the design of anti-tetanus and anti-botulism
therapeutic agents.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Fig. 5. Stereo view of the surfaces of the two binding
sites of H[C] with the interacting ganglioside. The Gal4-GalNAc3
site is a deep cleft on one H[C] (red) and the Sia7-Sia6 a
shallow groove on the other (blue). The protein residues forming
the binding sites are shown.
|
 |
Figure 6.
Fig. 6. Stereo view of the ganglioside-protein binding
sites. a, the Gal4-GalNAc3 site is a groove formed by Trp1289,
His1271, and Tyr1290. The hydrophobic face of Gal4 packs against
the indole ring of Trp1289. This packing is extended through
His1293, Phe^1218, and His1271. Hydrogen bonds are shown as
dotted lines. b, the Sia7-Sia6 site consists of residues
Asp1147, Arg1226, Asn1216, Asp1214, and Tyr1229. The disialo
group binds to the protein through hydrogen bonds that are shown
as dotted lines.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
32274-32281)
copyright 2001.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Oliveira,
M.Rangl,
A.Ebner,
B.Mayer,
P.Hinterdorfer,
and
A.P.Pêgo
(2011).
Molecular recognition force spectroscopy: a new tool to tailor targeted nanoparticles.
|
| |
Small,
7,
1236-1241.
|
 |
|
|
|
|
 |
A.F.Bongat,
R.Saksena,
R.Adamo,
Y.Fujimoto,
Z.Shiokawa,
D.C.Peterson,
K.Fukase,
W.F.Vann,
and
P.Kovác
(2010).
Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant.
|
| |
Glycoconj J,
27,
69-77.
|
 |
|
|
|
|
 |
J.Strotmeier,
K.Lee,
A.K.Völker,
S.Mahrhold,
Y.Zong,
J.Zeiser,
J.Zhou,
A.Pich,
H.Bigalke,
T.Binz,
A.Rummel,
and
R.Jin
(2010).
Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
|
| |
Biochem J,
431,
207-216.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Scott,
O.Qazi,
M.J.Wright,
N.F.Fairweather,
and
M.P.Deonarain
(2010).
Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding.
|
| |
Mol Immunol,
47,
1931-1941.
|
 |
|
|
|
|
 |
A.Rummel,
K.Häfner,
S.Mahrhold,
N.Darashchonak,
M.Holt,
R.Jahn,
S.Beermann,
T.Karnath,
H.Bigalke,
and
T.Binz
(2009).
Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
|
| |
J Neurochem,
110,
1942-1954.
|
 |
|
|
|
|
 |
C.Chen,
Z.Fu,
J.J.Kim,
J.T.Barbieri,
and
M.R.Baldwin
(2009).
Gangliosides as high affinity receptors for tetanus neurotoxin.
|
| |
J Biol Chem,
284,
26569-26577.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.R.Popoff,
and
P.Bouvet
(2009).
Clostridial toxins.
|
| |
Future Microbiol,
4,
1021-1064.
|
 |
|
|
|
|
 |
R.F.Fischetti,
S.Xu,
D.W.Yoder,
M.Becker,
V.Nagarajan,
R.Sanishvili,
M.C.Hilgart,
S.Stepanov,
O.Makarov,
and
J.L.Smith
(2009).
Mini-beam collimator enables microcrystallography experiments on standard beamlines.
|
| |
J Synchrotron Radiat,
16,
217-225.
|
 |
|
|
|
|
 |
U.Neu,
T.Stehle,
and
W.J.Atwood
(2009).
The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry.
|
| |
Virology,
384,
389-399.
|
 |
|
|
|
|
 |
Z.Fu,
C.Chen,
J.T.Barbieri,
J.J.Kim,
and
M.R.Baldwin
(2009).
Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
|
| |
Biochemistry,
48,
5631-5641.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Andreu,
N.Fairweather,
and
A.D.Miller
(2008).
Clostridium neurotoxin fragments as potential targeting moieties for liposomal gene delivery to the CNS.
|
| |
Chembiochem,
9,
219-231.
|
 |
|
|
|
|
 |
A.Imberty,
and
A.Varrot
(2008).
Microbial recognition of human cell surface glycoconjugates.
|
| |
Curr Opin Struct Biol,
18,
567-576.
|
 |
|
|
|
|
 |
P.Stenmark,
J.Dupuy,
A.Imamura,
M.Kiso,
and
R.C.Stevens
(2008).
Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction.
|
| |
PLoS Pathog,
4,
e1000129.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Sanishvili,
V.Nagarajan,
D.Yoder,
M.Becker,
S.Xu,
S.Corcoran,
D.L.Akey,
J.L.Smith,
and
R.F.Fischetti
(2008).
A 7 microm mini-beam improves diffraction data from small or imperfect crystals of macromolecules.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
425-435.
|
 |
|
|
|
|
 |
A.Krisko,
and
C.Etchebest
(2007).
Theoretical model of human apolipoprotein B100 tertiary structure.
|
| |
Proteins,
66,
342-358.
|
 |
|
|
|
|
 |
A.Rummel,
T.Eichner,
T.Weil,
T.Karnath,
A.Gutcaits,
S.Mahrhold,
K.Sandhoff,
R.L.Proia,
K.R.Acharya,
H.Bigalke,
and
T.Binz
(2007).
Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.
|
| |
Proc Natl Acad Sci U S A,
104,
359-364.
|
 |
|
|
|
|
 |
R.Gornati,
V.Chini,
S.Rimoldi,
M.Meregalli,
E.Schiaffino,
and
G.Bernardini
(2007).
Evaluation of SAT-1, SAT-2 and GalNAcT-1 mRNA in colon cancer by real-time PCR.
|
| |
Mol Cell Biochem,
298,
59-68.
|
 |
|
|
|
|
 |
A.L.Slade,
J.S.Schoeniger,
D.Y.Sasaki,
and
C.M.Yip
(2006).
In situ scanning probe microscopy studies of tetanus toxin-membrane interactions.
|
| |
Biophys J,
91,
4565-4574.
|
 |
|
|
|
|
 |
M.C.Conway,
R.M.Whittal,
M.A.Baldwin,
A.L.Burlingame,
and
R.Balhorn
(2006).
Electrospray mass spectrometry of NeuAc oligomers associated with the C fragment of the tetanus toxin.
|
| |
J Am Soc Mass Spectrom,
17,
967-976.
|
 |
|
|
|
|
 |
M.M.Ngundi,
C.R.Taitt,
and
F.S.Ligler
(2006).
Simultaneous determination of kinetic parameters for the binding of cholera toxin to immobilized sialic acid and monoclonal antibody using an array biosensor.
|
| |
Biosens Bioelectron,
22,
124-130.
|
 |
|
|
|
|
 |
M.M.Ngundi,
C.R.Taitt,
S.A.McMurry,
D.Kahne,
and
F.S.Ligler
(2006).
Detection of bacterial toxins with monosaccharide arrays.
|
| |
Biosens Bioelectron,
21,
1195-1201.
|
 |
|
|
|
|
 |
O.Qazi,
D.Sesardic,
R.Tierney,
Z.Söderbäck,
D.Crane,
B.Bolgiano,
and
N.Fairweather
(2006).
Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
|
| |
Infect Immun,
74,
4884-4891.
|
 |
|
|
|
|
 |
Q.Chai,
J.W.Arndt,
M.Dong,
W.H.Tepp,
E.A.Johnson,
E.R.Chapman,
and
R.C.Stevens
(2006).
Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
|
| |
Nature,
444,
1096-1100.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Jayaraman,
S.Eswaramoorthy,
D.Kumaran,
and
S.Swaminathan
(2005).
Common binding site for disialyllactose and tri-peptide in C-fragment of tetanus neurotoxin.
|
| |
Proteins,
61,
288-295.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Rummel,
S.Mahrhold,
H.Bigalke,
and
T.Binz
(2004).
The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
|
| |
Mol Microbiol,
51,
631-643.
|
 |
|
|
|
|
 |
C.Montecucco,
O.Rossetto,
and
G.Schiavo
(2004).
Presynaptic receptor arrays for clostridial neurotoxins.
|
| |
Trends Microbiol,
12,
442-446.
|
 |
|
|
|
|
 |
J.B.Park,
and
L.L.Simpson
(2004).
Progress toward development of an inhalation vaccine against botulinum toxin.
|
| |
Expert Rev Vaccines,
3,
477-487.
|
 |
|
|
|
|
 |
L.L.Simpson
(2004).
Identification of the major steps in botulinum toxin action.
|
| |
Annu Rev Pharmacol Toxicol,
44,
167-193.
|
 |
|
|
|
|
 |
B.M.Paddle
(2003).
Therapy and prophylaxis of inhaled biological toxins.
|
| |
J Appl Toxicol,
23,
139-170.
|
 |
|
|
|
|
 |
G.Lalli,
S.Bohnert,
K.Deinhardt,
C.Verastegui,
and
G.Schiavo
(2003).
The journey of tetanus and botulinum neurotoxins in neurons.
|
| |
Trends Microbiol,
11,
431-437.
|
 |
|
|
|
|
 |
A.Nowakowski,
C.Wang,
D.B.Powers,
P.Amersdorfer,
T.J.Smith,
V.A.Montgomery,
R.Sheridan,
R.Blake,
L.A.Smith,
and
J.D.Marks
(2002).
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.
|
| |
Proc Natl Acad Sci U S A,
99,
11346-11350.
|
 |
|
|
|
|
 |
K.Turton,
J.A.Chaddock,
and
K.R.Acharya
(2002).
Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.
|
| |
Trends Biochem Sci,
27,
552-558.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |